• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Circulating cell-free high mobility group AT-hook 2 mRNA as a detection marker in the serum of colorectal cancer patients.循环游离高迁移率族AT钩蛋白2信使核糖核酸作为结直肠癌患者血清中的一种检测标志物
J Clin Lab Anal. 2018 May;32(4):e22332. doi: 10.1002/jcla.22332. Epub 2017 Sep 26.
2
Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer.上皮性卵巢癌患者血浆中高迁移率族蛋白A2特异性mRNA的检测
Oncotarget. 2015 Aug 7;6(22):19328-35. doi: 10.18632/oncotarget.2896.
3
Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.循环高迁移率族 AT 钩蛋白 2 和多形性腺瘤基因 1 在口腔鳞状细胞癌患者的血液中。
J Oral Pathol Med. 2017 Nov;46(10):998-1003. doi: 10.1111/jop.12609. Epub 2017 Jul 24.
4
Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.游离 BIRC5 mRNA 作为结直肠癌血清诊断和预后生物标志物的研究。
J Surg Oncol. 2014 May;109(6):574-9. doi: 10.1002/jso.23526. Epub 2013 Dec 11.
5
rs968697 T > C polymorphism is associated with the risk of colorectal cancer.rs968697 T>C 多态性与结直肠癌风险相关。
Nucleosides Nucleotides Nucleic Acids. 2021;40(8):821-828. doi: 10.1080/15257770.2021.1952596. Epub 2021 Jul 21.
6
Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.let-7a-5p的下调可预测结直肠癌的淋巴结转移和预后:对化疗的意义。
Surg Oncol. 2016 Dec;25(4):429-434. doi: 10.1016/j.suronc.2016.05.016. Epub 2016 May 27.
7
HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.HMGA2与侵袭性相关,但并非检测乳腺癌循环肿瘤细胞的合适标志物。
Oncol Rep. 2005 Sep;14(3):737-41.
8
Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.血清 Metadherin mRNA 表达在结直肠癌患者诊断和预后预测中的作用。
Mol Biol Rep. 2020 Apr;47(4):2509-2519. doi: 10.1007/s11033-020-05334-5. Epub 2020 Feb 22.
9
Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.HMGA2 的过表达促进结直肠癌的转移并影响其生存。
Clin Cancer Res. 2011 Apr 15;17(8):2570-80. doi: 10.1158/1078-0432.CCR-10-2542. Epub 2011 Jan 20.
10
Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.骨膜蛋白的循环水平可能有助于识别侵袭性更强的结直肠癌患者。
Int J Oncol. 2009 Mar;34(3):821-8. doi: 10.3892/ijo_00000208.

引用本文的文献

1
HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report.HMGA1 基因在非小细胞肺癌(NSCLC)患者癌组织和血液样本中的表达水平:初步报告。
Mol Genet Genomics. 2022 Nov;297(6):1505-1514. doi: 10.1007/s00438-022-01936-9. Epub 2022 Aug 10.
2
Circle RNA circ_0007331 promotes colorectal carcinoma by targeting miR-205-5p/high-mobility group A2 axis.环状 RNA circ_0007331 通过靶向 miR-205-5p/高迁移率族蛋白 A2 轴促进结直肠癌。
Bioengineered. 2022 Apr;13(4):9312-9321. doi: 10.1080/21655979.2022.2051857.
3
Circulating , , and mRNA in Peripheral Blood and Serum as Potential Biomarkers for Patients with Metastatic Colon Cancer.外周血和血清中循环的 、 、 和 mRNA 作为转移性结肠癌患者的潜在生物标志物
J Clin Med. 2021 May 22;10(11):2248. doi: 10.3390/jcm10112248.
4
The Roadmap of Colorectal Cancer Screening.结直肠癌筛查路线图
Cancers (Basel). 2021 Mar 4;13(5):1101. doi: 10.3390/cancers13051101.
5
Emerging roles for HMGA2 in colorectal cancer.HMGA2在结直肠癌中的新作用。
Transl Oncol. 2021 Jan;14(1):100894. doi: 10.1016/j.tranon.2020.100894. Epub 2020 Oct 14.
6
The Prominent Role of HMGA Proteins in the Early Management of Gastrointestinal Cancers.HMGA 蛋白在胃肠道癌的早期管理中的突出作用。
Biomed Res Int. 2019 Oct 13;2019:2059516. doi: 10.1155/2019/2059516. eCollection 2019.
7
The Prospect and Challenges to the Flow of Liquid Biopsy in Africa.液体活检在非洲的前景与挑战。
Cells. 2019 Aug 9;8(8):862. doi: 10.3390/cells8080862.

本文引用的文献

1
Establishing PNB-qPCR for quantifying minimal ctDNA concentrations during tumour resection.建立 PNB-qPCR 以定量检测肿瘤切除过程中的最小 ctDNA 浓度。
Sci Rep. 2017 Aug 21;7(1):8876. doi: 10.1038/s41598-017-09137-w.
2
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.循环游离 DNA 中的 5-羟甲基胞嘧啶特征可提供有关肿瘤类型和分期的信息。
Cell Res. 2017 Oct;27(10):1231-1242. doi: 10.1038/cr.2017.106. Epub 2017 Aug 18.
3
Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA.单色数字PCR可对循环DNA中的癌症突变进行高性能检测。
J Mol Diagn. 2017 Sep;19(5):697-710. doi: 10.1016/j.jmoldx.2017.05.003. Epub 2017 Aug 14.
4
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.血浆 Epstein-Barr 病毒 DNA 分析用于筛查鼻咽癌。
N Engl J Med. 2017 Aug 10;377(6):513-522. doi: 10.1056/NEJMoa1701717.
5
Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer.液体活检:癌症动态基因分型方法。
Oncol Res Treat. 2017;40(7-8):409-416. doi: 10.1159/000478864. Epub 2017 Jul 13.
6
Liquid Biopsy: Current Status and Future Perspectives.液体活检:现状与未来展望。
Oncol Res Treat. 2017;40(7-8):404-408. doi: 10.1159/000478018. Epub 2017 Jul 13.
7
Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma.循环肿瘤DNA(ctDNA)作为黑色素瘤的液体活检
Cancer Lett. 2017 Sep 28;404:62-69. doi: 10.1016/j.canlet.2017.06.030. Epub 2017 Jul 4.
8
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid.循环游离核酸临床下一代测序的分析前和分析变量研究
J Mol Diagn. 2017 Jul;19(4):514-524. doi: 10.1016/j.jmoldx.2017.03.003. Epub 2017 May 12.
9
Circulating cell-free microRNAs as clinical cancer biomarkers.循环游离微小RNA作为临床癌症生物标志物
Biomol Concepts. 2017 May 24;8(2):61-81. doi: 10.1515/bmc-2017-0002.
10
Clinical verification of plasma messenger RNA as novel noninvasive biomarker identified through bioinformatics analysis for lung cancer.通过生物信息学分析鉴定的血浆信使核糖核酸作为肺癌新型非侵入性生物标志物的临床验证。
Oncotarget. 2017 Jul 4;8(27):43978-43989. doi: 10.18632/oncotarget.16701.

循环游离高迁移率族AT钩蛋白2信使核糖核酸作为结直肠癌患者血清中的一种检测标志物

Circulating cell-free high mobility group AT-hook 2 mRNA as a detection marker in the serum of colorectal cancer patients.

作者信息

Sahengbieke Sana, Wang Jian, Li Xiangwei, Wang Yuhong, Lai Maode, Wu Jingjing

机构信息

Department of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

出版信息

J Clin Lab Anal. 2018 May;32(4):e22332. doi: 10.1002/jcla.22332. Epub 2017 Sep 26.

DOI:10.1002/jcla.22332
PMID:28948632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6817123/
Abstract

BACKGROUND

Detection of circulating cell-free mRNA serves as noninvasive tools for cancer diagnosis. As an oncofetal protein, HMGA2 (high mobility group AT-hook 2) is upregulated in colorectal cancer (CRC) tissues. However, it is not clear whether the increased levels of circulating cell-free HMGA2 mRNA functions as potential biomarkers for improved diagnosis of CRC.

METHODS

To assess its clinical significance in diagnosis and prediction, we evaluated serum levels of circulating HMGA2 mRNA in CRC patients and in healthy controls. In this study, 83 CRC patients and 11 normal controls were enrolled in this study. We used real-time quantitative reverse transcription-PCR to evaluate the plasma mRNA levels of HMGA2 and analyze the correlation between their expression and clinicopathologic characteristics.

RESULTS

We found that the levels of HMGA2 mRNA were significantly higher in CRC patients compared with healthy volunteers. The patients with right-sided CRC, colon cancer, positive nerve infiltration, positive vascular invasion, negative microsatellite instability (MSI), and increasing in serum carbohydrate antigen (CA) 199 had higher levels of plasma HMGA2 mRNA. A strong positive correlation between circulating cell-free HMGA2 mRNA and CA199 level in serum was found in our study. Furthermore, statistical analysis revealed that levels of HMGA2 mRNA in plasma and in tumors were strictly correlated.

CONCLUSIONS

Collectively, our data suggested that cell-free HMGA2 mRNA in plasma might function as a novel diagnostic marker for CRC.

摘要

背景

循环游离mRNA的检测作为癌症诊断的非侵入性工具。HMGA2(高迁移率族AT钩蛋白2)作为一种癌胚蛋白,在结直肠癌(CRC)组织中上调。然而,尚不清楚循环游离HMGA2 mRNA水平升高是否可作为改善CRC诊断的潜在生物标志物。

方法

为评估其在诊断和预测中的临床意义,我们评估了CRC患者和健康对照者血清中循环HMGA2 mRNA的水平。本研究纳入了83例CRC患者和11例正常对照。我们使用实时定量逆转录PCR来评估HMGA2的血浆mRNA水平,并分析其表达与临床病理特征之间的相关性。

结果

我们发现,与健康志愿者相比,CRC患者中HMGA2 mRNA水平显著更高。右侧CRC、结肠癌、神经浸润阳性、血管侵犯阳性、微卫星不稳定性(MSI)阴性以及血清糖类抗原(CA)199升高的患者血浆HMGA2 mRNA水平更高。我们的研究发现循环游离HMGA2 mRNA与血清CA199水平之间存在强正相关。此外, 统计分析显示血浆和肿瘤中HMGA2 mRNA水平密切相关。

结论

总体而言,我们的数据表明血浆中游离HMGA2 mRNA可能作为CRC的一种新型诊断标志物。